Co-Diagnostics Inc. (NASDAQ: CODX) stock closed at 1.18 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 50.68K shares and market capitalization of 36.08M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 39 people. Co-Diagnostics Inc. CEO is Dwight H Egan.

The one-year performance of Co-Diagnostics Inc. stock is -60.8%, while year-to-date (YTD) performance is -53.17%. CODX stock has a five-year performance of -43%. Its 52-week range is between 0.975 and 3.33, which gives CODX stock a 52-week price range ratio of 8.70%

Co-Diagnostics Inc. currently has a PE ratio of 5.40, a price-to-book (PB) ratio of 0.58, a price-to-sale (PS) ratio of 2.47, a price to cashflow ratio of 5.30, a PEG ratio of -, a ROA of 12.79%, a ROC of 12.56% and a ROE of 13.80%. The company’s profit margin is 23.36%, its EBITDA margin is 19.80%, and its revenue ttm is $32.82 Million , which makes it $1.06 revenue per share.

Of the last four earnings reports from Co-Diagnostics Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.29 for the next earnings report. Co-Diagnostics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Co-Diagnostics Inc. is Hold (3), with a target price of $12, which is +916.95% compared to the current price. The earnings rating for Co-Diagnostics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Co-Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Co-Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.03, ATR14 : 0.13, CCI20 : -44.11, Chaikin Money Flow : -0.27, MACD : 0.01, Money Flow Index : 50.26, ROC : 3.51, RSI : 48.74, STOCH (14,3) : 24.53, STOCH RSI : 0.27, UO : 36.51, Williams %R : -75.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Co-Diagnostics Inc. in the last 12-months were: Brian L. Brown (Buy at a value of $5 697), Brian Lee Brown (Buy at a value of $5 700), Brian Lee Brown (Sold 199 166 shares of value $0 ), Durenard Eugene (Sold 60 833 shares of value $0 ), Dwight Egan (Sold 255 834 shares of value $0 ), James B. Nelson (Sold 30 000 shares of value $0 ), Murphy Ted (Sold 60 833 shares of value $0 ), Serbin Richard (Sold 60 833 shares of value $0 )